{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T23:47:45Z","timestamp":1770076065229,"version":"3.49.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Emergency Medicine Clinics of North America"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.emc.2025.03.006","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T19:01:38Z","timestamp":1745866898000},"page":"431-444","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Leukopenia and Neutropenic Fever"],"prefix":"10.1016","volume":"43","author":[{"given":"Nicholas","family":"Pettit","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.emc.2025.03.006_bib1","series-title":"Small Animal Clinical Diagnosis by Laboratory Methods","first-page":"63","article-title":"Leukocyte disorders","author":"Tvedten","year":"2012"},{"issue":"1","key":"10.1016\/j.emc.2025.03.006_bib2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1200\/JOP.18.00269","article-title":"Optimal management of neutropenic fever in patients with cancer","volume":"15","author":"Zimmer","year":"2019","journal-title":"J Oncol Pract"},{"issue":"9","key":"10.1016\/j.emc.2025.03.006_bib3","doi-asserted-by":"crossref","first-page":"7067","DOI":"10.1007\/s00520-022-07103-5","article-title":"Current state and future opportunities in granulocyte colony-stimulating factor (G-CSF)","volume":"30","author":"Link","year":"2022","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.emc.2025.03.006_bib4","author":"Punnapuzha"},{"issue":"35","key":"10.1016\/j.emc.2025.03.006_bib5","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000016993","article-title":"Parvovirus B19 infection presenting with neutropenia and thrombocytopenia: three case reports","volume":"98","author":"Shin","year":"2019","journal-title":"Medicine (Baltim)"},{"issue":"11","key":"10.1016\/j.emc.2025.03.006_bib6","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1002\/cncr.11827","article-title":"Risk and timing of hospitalization for febrile neutropenia in patients receiving CHOP, CHOP-R, or CNOP chemotherapy for intermediate-grade non-Hodgkin lymphoma","volume":"98","author":"Lyman","year":"2003","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.emc.2025.03.006_bib7","doi-asserted-by":"crossref","first-page":"720","DOI":"10.3111\/13696998.2013.782034","article-title":"A retrospective study of the clinical and economic burden during hospitalizations among cancer patients with febrile neutropenia","volume":"16","author":"Dulisse","year":"2013","journal-title":"J Med Econ"},{"key":"10.1016\/j.emc.2025.03.006_bib8","first-page":"1297","article-title":"Neutropenic fever in the intensive care unit","author":"Stephens","year":"2019","journal-title":"Oncologic Critical Care"},{"issue":"9","key":"10.1016\/j.emc.2025.03.006_bib9","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1002\/cncr.20983","article-title":"Incidence, cost, and mortality of neutropenia hospitalization associated with chemotherapy","volume":"109","author":"Caggiano","year":"2005","journal-title":"Cancer"},{"issue":"Suppl 1","key":"10.1016\/j.emc.2025.03.006_bib10","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1086\/383050","article-title":"Management of fever in neutropenic patients with different risks of complications","volume":"39","author":"Klastersky","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"9 Suppl 8","key":"10.1016\/j.emc.2025.03.006_bib11","first-page":"21","article-title":"Dose reductions and delays: limitations of myelosuppressive chemotherapy","volume":"14","author":"Cairo","year":"2000","journal-title":"Oncology (Williston Park)"},{"issue":"3","key":"10.1016\/j.emc.2025.03.006_bib12","doi-asserted-by":"crossref","first-page":"725","DOI":"10.3892\/mco.2015.524","article-title":"Epidemiology and characteristics of febrile neutropenia in oncology patients from Spanish tertiary care hospitals: PINNACLE study","volume":"3","author":"Castro Carpeno","year":"2015","journal-title":"Mol Clin Oncol"},{"issue":"Suppl 1","key":"10.1016\/j.emc.2025.03.006_bib13","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/S0959-8049(99)00259-2","article-title":"Chemotherapy dose reduction and delay in clinical practice. Evaluating the risk to patient outcome in adjuvant chemotherapy for breast cancer","volume":"36","author":"Chang","year":"2000","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.emc.2025.03.006_bib14","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/MCP.0000000000000156","article-title":"Pneumonia in the neutropenic cancer patient","volume":"21","author":"Evans","year":"2015","journal-title":"Curr Opin Pulm Med"},{"issue":"9","key":"10.1016\/j.emc.2025.03.006_bib15","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1007\/s00520-015-2631-y","article-title":"The signs, symptoms and help-seeking experiences of neutropenic sepsis patients before they reach hospital: a qualitative study","volume":"23","author":"Clarke","year":"2015","journal-title":"Support Care Cancer"},{"issue":"5","key":"10.1016\/j.emc.2025.03.006_bib16","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s00277-014-2273-z","article-title":"Association between early peak temperature and mortality in neutropenic sepsis","volume":"94","author":"Weinkove","year":"2015","journal-title":"Ann Hematol"},{"issue":"23","key":"10.1016\/j.emc.2025.03.006_bib17","doi-asserted-by":"crossref","first-page":"8475","DOI":"10.1002\/cam4.4355","article-title":"The role of procalcitonin in identifying high-risk cancer patients with febrile neutropenia: a useful alternative to the Multinational Association for Supportive Care in Cancer score","volume":"10","author":"Chaftari","year":"2021","journal-title":"Cancer Med"},{"key":"10.1016\/j.emc.2025.03.006_bib18","article-title":"Approach to fever in patients with neutropenia: a review of diagnosis and management","volume":"9","author":"Keck","year":"2022","journal-title":"Ther Adv Infect Dis"},{"issue":"7","key":"10.1016\/j.emc.2025.03.006_bib19","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1128\/AAC.02561-14","article-title":"Cohort study of the impact of time to antibiotic administration on mortality in patients with febrile neutropenia","volume":"58","author":"Rosa","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"10.1016\/j.emc.2025.03.006_bib20","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJMoa1711586","article-title":"Balanced crystalloids versus saline in noncritically ill adults","volume":"378","author":"Self","year":"2018","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.emc.2025.03.006_bib21","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.1007\/s11605-021-05116-9","article-title":"Gastrointestinal surgical emergencies in the neutropenic immunocompromised patient","volume":"25","author":"White","year":"2021","journal-title":"J Gastrointest Surg"},{"issue":"20","key":"10.1016\/j.emc.2025.03.006_bib22","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.3390\/cells11203314","article-title":"Morbidity and mortality of neutropenic patients in visceral surgery: a narrative review","volume":"11","author":"Lederer","year":"2022","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.emc.2025.03.006_bib23","doi-asserted-by":"crossref","first-page":"118","DOI":"10.38175\/phnx.992230","article-title":"Scoring systems identifying the low-risk febril neutropenia patients in the emergency department: usefulness of MASCC, CISNE and qSOFA","volume":"3","author":"\u0130pekci","year":"2021","journal-title":"Phoenix Medical Journal"},{"issue":"1","key":"10.1016\/j.emc.2025.03.006_bib24","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jemermed.2022.10.010","article-title":"Can risk stratification tools Be utilized to safely discharge low-risk febrile neutropenic patients from the emergency department?","volume":"64","author":"Chen","year":"2023","journal-title":"J Emerg Med"},{"issue":"6","key":"10.1016\/j.emc.2025.03.006_bib25","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.annemergmed.2016.11.007","article-title":"Application of the MASCC and CISNE risk-stratification scores to identify low-risk febrile neutropenic patients in the emergency department","volume":"69","author":"Coyne","year":"2017","journal-title":"Ann Emerg Med"},{"issue":"1","key":"10.1016\/j.emc.2025.03.006_bib26","first-page":"39","article-title":"Clinical characteristics and associated factors of mortality in febrile neutropenia patients; a cross sectional study","volume":"7","author":"Hatamabadi","year":"2019","journal-title":"Arch Acad Emerg Med"},{"issue":"4","key":"10.1016\/j.emc.2025.03.006_bib27","doi-asserted-by":"crossref","first-page":"e582","DOI":"10.1200\/OP.20.00115","article-title":"Mortality among neutropenic cancer patients within the United States: the association with hospital volume","volume":"17","author":"Urban","year":"2021","journal-title":"JCO Oncol Pract"},{"issue":"4","key":"10.1016\/j.emc.2025.03.006_bib28","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1177\/1078155219879494","article-title":"Fatal neutropenic enterocolitis associated with docetaxel use: a review of cases reported to the United States Food and Drug Administration Adverse Event Reporting System","volume":"26","author":"Singh","year":"2020","journal-title":"J Oncol Pharm Pract"},{"key":"10.1016\/j.emc.2025.03.006_bib29","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1472-6955-4-4","article-title":"Experiencing neutropenia: quality of life interviews with adult cancer patients","volume":"4","author":"Fortner","year":"2005","journal-title":"BMC Nurs"}],"container-title":["Emergency Medicine Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733862725000173?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733862725000173?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T22:46:42Z","timestamp":1751410002000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733862725000173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S0733862725000173"],"URL":"https:\/\/doi.org\/10.1016\/j.emc.2025.03.006","relation":{},"ISSN":["0733-8627"],"issn-type":[{"value":"0733-8627","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Leukopenia and Neutropenic Fever","name":"articletitle","label":"Article Title"},{"value":"Emergency Medicine Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.emc.2025.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}